Outsourcing-pharma6d
Ethris reports positive phase 1 results for asthma mRNA therapy
Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed ...
Outsourcing-pharma8d
Novo Nordisk’s next-generation obesity drug shows promise in early clinical trials
Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...
Outsourcing-pharma8d
Manas AI bags $24.6 million to turbocharge drug discovery
Manas AI secures funding led by General Catalyst to scale AI-driven drug discovery, tackling cancer and rare diseases.
Outsourcing-pharma13d
The largest pharma acquisitions of 2024
From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024 ...
Outsourcing-pharma8d
Women in Science: Émilie Barré on her passion for applying data to real-world challenges
Throughout her career, One2Treat’s Émilie Barré has focused on developing both the analytical and leadership aspects ...
Outsourcing-pharma6d
Lantheus to acquire Evergreen in $1bn deal to expand radiopharmaceutical pipeline
Lantheus is acquiring radiopharmaceutical CDMO Evergreen Theragnostics in a deal worth up to $1 billion, expanding its manufacturing capabilities and drug pipeline. The acquisition includes Octevy, a ...
Outsourcing-pharma13d
Arctic Therapeutics to tackle dementia and skin disease with €26.5 million series A
Arctic therapeutics raises funding from EIC Fund, Kaldbakur, and Sanos Group to advance its dementia treatment, AT-001, and acne drug, AT-004. The company aims to transform the treatment landscape for ...